Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanifibranor in Adult Patients With Non-cirrhotic NASH and Fibrosis Stages F2 and F3
NCT04849728Phase 3Active, not recruiting
- Sponsor
- Inventiva
- Start
- Aug 2021
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of lanifibranor in Nonalcoholic steatohepatitis (NASH), sponsored by Inventiva. Started Aug 2021; status: active, not recruiting.
02
Drugs
lanifibranor
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04849728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04849728.